CD4+ T cells specific for factor VIII as a target for specific suppression of inhibitor production.

[1]  D. Okita,et al.  Universal epitopes for human CD4+ cells on tetanus and diphtheria toxins. , 2000, The Journal of infectious diseases.

[2]  M. Grusby,et al.  Orally induced peripheral nonresponsiveness is maintained in the absence of functional Th1 or Th2 cells. , 1999, Journal of immunology.

[3]  P. Karachunski,et al.  Interleukin-4 deficiency facilitates development of experimental myasthenia gravis and precludes its prevention by nasal administration of CD4+ epitope sequences of the acetylcholine receptor , 1999, Journal of Neuroimmunology.

[4]  R. Garman,et al.  Subcutaneous administration of T-epitope sequences of the acetylcholine receptor prevents experimental myasthenia gravis , 1999, Journal of Neuroimmunology.

[5]  K. Garcia,et al.  Structural basis of T cell recognition. , 1999, Annual review of immunology.

[6]  E. Getzoff,et al.  Homology models of the C domains of blood coagulation factors V and VIII: a proposed membrane binding mode for FV and FVIII C2 domains. , 1998, Blood cells, molecules & diseases.

[7]  R. Stevens,et al.  Crystal structure of botulinum neurotoxin type A and implications for toxicity , 1998, Nature Structural Biology.

[8]  K. Murphy,et al.  Low Dose TGF-β Attenuates IL-12 Responsiveness in Murine Th Cells , 1998, The Journal of Immunology.

[9]  S. Sriram,et al.  TGF-beta inhibits IL-12-induced activation of Jak-STAT pathway in T lymphocytes. , 1998, Journal of immunology.

[10]  C. Kessler,et al.  Factor VIII immunogenicity , 1998, Haemophilia : the official journal of the World Federation of Hemophilia.

[11]  M. Shima,et al.  Some human inhibitor antibodies interfere with factor VIII binding to factor IX. , 1998, Blood.

[12]  A. Roberts,et al.  Factors involved in the differentiation of TGF-beta-producing cells from naive CD4+ T cells: IL-4 and IFN-gamma have opposing effects, while TGF-beta positively regulates its own production. , 1998, Journal of immunology.

[13]  E. Sercarz,et al.  Modulation of the immunogenicity of antigenic determinants by their flanking residues. , 1998, Immunology today.

[14]  N. Sarvetnick,et al.  TGF-beta1 alters APC preference, polarizing islet antigen responses toward a Th2 phenotype. , 1998, Immunity.

[15]  Anita B. Roberts,et al.  REGULATION OF IMMUNE RESPONSES BY TGF-β* , 1998 .

[16]  A. O’Garra,et al.  Cytokines induce the development of functionally heterogeneous T helper cell subsets. , 1998, Immunity.

[17]  P. Karachunski,et al.  Prevention of experimental myasthenia gravis by nasal administration of synthetic acetylcholine receptor T epitope sequences. , 1997, The Journal of clinical investigation.

[18]  P. Lehmann,et al.  Determinant Spreading of  T Helper Cell 2 (Th2) Responses to Pancreatic Islet Autoantigens , 1997, The Journal of experimental medicine.

[19]  L. Steinman,et al.  CD4+ T-cell subsets in autoimmunity. , 1997, Current opinion in immunology.

[20]  W. Weigle,et al.  CD4+ T-cell subsets and cytokines involved in peripheral tolerance. , 1997, Immunology today.

[21]  S. Landry,et al.  Local protein instability predictive of helper T-cell epitopes. , 1997, Immunology today.

[22]  S. Swaminathan,et al.  Structure of the receptor binding fragment HC of tetanus neurotoxin , 1997, Nature Structural Biology.

[23]  J. Saint-Remy,et al.  Factor VIII Inhibitors , 1997, Thrombosis and Haemostasis.

[24]  S. Romagnani,et al.  The Th1/Th2 paradigm. , 1997, Immunology today.

[25]  P. Salgame,et al.  Differential ability of T cell subsets to undergo activation-induced cell death. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[26]  D. Green,et al.  Unequal Death in T Helper Cell (Th)1 and Th2 Effectors: Th1, but not Th2, Effectors Undergo Rapid Fas/FasL-mediated Apoptosis , 1997, The Journal of experimental medicine.

[27]  G. Card,et al.  A molecular model for the triplicated A domains of human factor VIII based on the crystal structure of human ceruloplasmin. , 1997, Blood.

[28]  D. Okita,et al.  Epitope repertoire of human CD4+ T cells on tetanus toxin: identification of immunodominant sequence segments. , 1997, The Journal of infectious diseases.

[29]  C. Watts,et al.  Capture and processing of exogenous antigens for presentation on MHC molecules. , 1997, Annual review of immunology.

[30]  M. Bellone,et al.  Myasthenia Gravis: The Immunobiology of an Autoimmune Disease , 1996 .

[31]  S. Hauser,et al.  Late Complications of Immune Deviation Therapy in a Nonhuman Primate , 1996, Science.

[32]  Kenneth M. Murphy,et al.  Functional diversity of helper T lymphocytes , 1996, Nature.

[33]  A. Lucas,et al.  T Lymphocyte Proliferative Responses Induced by Recombinant Factor VIII in Hemophilia A Patients with Inhibitors , 1996, Thrombosis and Haemostasis.

[34]  R. Schwartz,et al.  Models of T Cell Anergy: Is There a Common Molecular Mechanism? , 1996 .

[35]  C. Kessler,et al.  9 Acquired inhibitors , 1996 .

[36]  J. Bluestone,et al.  CD28/B7 system of T cell costimulation. , 1996, Annual review of immunology.

[37]  C. Escuriola-Ettingshausen,et al.  Epidemiology of Inhibitors in Haemophilia A , 1996, Vox sanguinis.

[38]  C. Janeway,et al.  Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[39]  G. Cohen,et al.  Interactions of protein antigens with antibodies. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[40]  B M Conti-Fine,et al.  Antibodies as tools to study the structure of membrane proteins: the case of the nicotinic acetylcholine receptor. , 1996, Annual review of biophysics and biomolecular structure.

[41]  J. Kraehenbuhl,et al.  Antigen sampling across epithelial barriers and induction of mucosal immune responses. , 1996, Annual review of immunology.

[42]  D. Mccormick,et al.  Epitopes for human CD4+ cells on diphtheria toxin: Structural features of sequence segments forming epitopes recognized by most subjects , 1995, European journal of immunology.

[43]  M. Shima,et al.  Common inhibitory effects of human anti‐C2 domain inhibitor alloantibodies on factor VIII binding to von Willebrand factor , 1995, British journal of haematology.

[44]  J. Morris,et al.  TSH receptor sequences recognized by CD4+ T cells in Graves' disease patients and healthy controls. , 1995, Journal of autoimmunity.

[45]  G. E. Gilbert,et al.  Some factor VIII inhibitor antibodies recognize a common epitope corresponding to C2 domain amino acids 2248 through 2312, which overlap a phospholipid-binding site. , 1995, Blood.

[46]  H. Weiner,et al.  Peripheral deletion of antigen-reactive T cells in oral tolerance , 1995, Nature.

[47]  T. Medsger,et al.  T cell proliferative response induced by DNA topoisomerase I in patients with systemic sclerosis and healthy donors. , 1995, The Journal of clinical investigation.

[48]  J. Healey,et al.  Residues 484-508 Contain a Major Determinant of the Inhibitory Epitope in the A2 Domain of Human Factor VIII (*) , 1995, The Journal of Biological Chemistry.

[49]  Warren Strober,et al.  Dominant interfering fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome , 1995, Cell.

[50]  F. Rieux-Laucat,et al.  Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. , 1995, Science.

[51]  G. Nossal.  Choices following antigen entry: antibody formation or immunologic tolerance? , 1995, Annual review of immunology.

[52]  D. Madden.  The three-dimensional structure of peptide-MHC complexes. , 1995, Annual review of immunology.

[53]  L. Hoyer.  The incidence of factor VIII inhibitors in patients with severe hemophilia A. , 1995, Advances in experimental medicine and biology.

[54]  L. Aledort,et al.  Inhibitors to Coagulation Factors , 1995, Advances in Experimental Medicine and Biology.

[55]  L. Aledort.  Inhibitors in hemophilia patients: Current status and management , 1994, American journal of hematology.

[56]  J. Saint-Remy,et al.  Healthy subjects produce both anti-factor VIII and specific anti-idiotypic antibodies. , 1994, The Journal of clinical investigation.

[57]  H. Weiner,et al.  Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[58]  C. Elson,et al.  Oral tolerance in humans. T cell but not B cell tolerance after antigen feeding. , 1994, Journal of immunology.

[59]  L. Hoyer,et al.  Factor VIII inhibitors: structure and function in autoantibody and hemophilia A patients. , 1994, Seminars in hematology.

[60]  Don C. Wiley,et al.  Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide , 1994, Nature.

[61]  L. Moiola,et al.  Epitopes on the beta subunit of human muscle acetylcholine receptor recognized by CD4+ cells of myasthenia gravis patients and healthy subjects. , 1994, The Journal of clinical investigation.

[62]  J. Goverman,et al.  T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. , 1994, Science.

[63]  J. Banchereau,et al.  Human interleukin 10 induces naive surface immunoglobulin D+ (sIgD+) B cells to secrete IgG1 and IgG3 , 1994, The Journal of experimental medicine.

[64]  V. Engelhard,et al.  Structure of peptides associated with class I and class II MHC molecules. , 1994, Annual review of immunology.

[65]  P. Cresswell,et al.  Assembly, transport, and function of MHC class II molecules. , 1994, Annual review of immunology.

[66]  H. Weiner,et al.  Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. , 1994, Annual review of immunology.

[67]  M. Jenkins,et al.  The role of anergy in peripheral T cell unresponsiveness. , 1994, Life sciences.

[68]  P. Matzinger.  Tolerance, danger, and the extended family. , 1994, Annual review of immunology.

[69]  S J Rodda,et al.  Mapping the major human T helper epitopes of tetanus toxin. The emerging picture. , 1993, Journal of immunology.

[70]  C. Caldwell,et al.  Human T cell clones reactive against U-small nuclear ribonucleoprotein autoantigens from connective tissue disease patients and healthy individuals. , 1993, Journal of immunology.

[71]  L. Donoso,et al.  Oral tolerance in experimental autoimmune uveoretinitis. Distinct mechanisms of resistance are induced by low dose vs high dose feeding protocols. , 1993, Journal of immunology.

[72]  K. Tadokoro,et al.  Recognition of human insulin in the context of HLA-DRB1*0406 products by T cells of insulin autoimmune syndrome patients and healthy donors. , 1993, Journal of immunology.

[73]  J. Arnout,et al.  Anti-factor VIII antibodies of hemophiliac patients are frequently directed towards nonfunctional determinants and do not exhibit isotypic restriction. , 1993, Blood.

[74]  R M Horton,et al.  Myasthenia gravis: recognition of a human autoantigen at the molecular level. , 1993, Immunology today.

[75]  William Arbuthnot Sir Lane,et al.  Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles , 1993, The Journal of experimental medicine.

[76]  G. Macpherson,et al.  Antigen acquisition by dendritic cells: intestinal dendritic cells acquire antigen administered orally and can prime naive T cells in vivo , 1993, The Journal of experimental medicine.

[77]  J. Goedert,et al.  Loss of high‐responder inhibitors in patients with severe hemophilia A and human immunodeficiency virus type 1 infection: A report from the multi‐center hemophilia cohort study , 1993, American journal of hematology.

[78]  R. Germain,et al.  The biochemistry and cell biology of antigen processing and presentation. , 1993, Annual review of immunology.

[79]  A Sette,et al.  Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. , 1992, Science.

[80]  Katherine A. Kantardjieff,et al.  The crystal structure of diphtheria toxin , 1992, Nature.

[81]  M. Kazatchkine,et al.  Natural antibodies to factor VIII (anti-hemophilic factor) in healthy individuals. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[82]  K. Rajewsky,et al.  Generation and analysis of interleukin-4 deficient mice. , 1991, Science.

[83]  A. Rudensky,et al.  Sequence analysis of peptides bound to MHC class II molecules , 1991, Nature.

[84]  Joshua R. Smith,et al.  T cell sensitization to factor VIII in haemophilia A? , 1991, British journal of haematology.

[85]  A. Abbas,et al.  Cellular and Molecular Immunology , 1991 .

[86]  L. Kappos,et al.  Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[87]  H. Weiner,et al.  T-cell recognition of an immuno-dominant myelin basic protein epitope in multiple sclerosis , 1990, Nature.

[88]  P. Ho,et al.  Identification of two promiscuous T cell epitopes from tetanus toxin , 1990, European journal of immunology.

[89]  B. Dahlbäck,et al.  Noncoagulation inhibitory factor VIII antibodies after induction of tolerance to factor VIII in hemophilia A patients. , 1990, Blood.

[90]  Antonio Lanzavecchia,et al.  Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells , 1989, European journal of immunology.

[91]  Antonio Lanzavecchia,et al.  Antigen-specific interaction between T and B cells , 1985, Nature.

[92]  B. Keyt,et al.  Structure of human factor VIII , 1984, Nature.

[93]  A. Engel.  Myasthenia gravis and myasthenic syndromes , 1984, Annals of neurology.

[94]  B. Zweiman,et al.  Isolation of myelin basic protein-reactive T-cell lines from normal human blood. , 1983, Cellular immunology.